BioNTech raises $150 mln for IPO: Reuters


German biotech firm BioNTech has raised $150 million for its U.S. IPO, reported Reuters. The stock, which began trading October 10, 2019, sold fewer shares and at a lower price than originally planned. J.P. Morgan, BofA Merrill Lynch, UBS and SVB Leerink are the lead undewriters. BioNTech is trading on the NASDAQ under the ticker symbol “BNTX.” BioNTech’s investors include Fidelity Management & Research Company.